Company
CapsoVision
Nasdaq: CV
Saratoga, California capsule-endoscopy maker, Nasdaq-listed since July 2025. CapsoCam Plus has been used in over 176,000 patients since its original 2016 clearance.
1 story
Regulatory News has published 1 story about CapsoVision on 29 September 2026, sourced to the primary record — the regulator’s decision, the company’s filing or its own announcement. This page is generated from that coverage. Last updated 29 September 2026.
This page is generated from Regulatory News’ editorial coverage of CapsoVision. It is not an advertisement.
On the record
- Company
- CapsoVision, Inc. (Nasdaq: CV)
- Headquarters
- Saratoga, California
- Founded
- 2005, by Kang-Huai (Johnny) Wang
- Regulator
- U.S. Food and Drug Administration (CDRH)
- Latest milestone
- FDA 510(k) clearance, AI Highlights for CapsoCam Plus
Each line is taken from the most recent story of ours that states it.
Products in our coverage
Our coverage
